Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials
Author:
Publisher
Elsevier BV
Subject
Anesthesiology and Pain Medicine
Reference58 articles.
1. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide;Gijsenbergh;Anesthesiology,2005
2. Sugammadex: what do we know and what do we still need to know? A review of the recent (2013 to 2014) literature;Ledowski;Anaesth Intensive Care,2015
3. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade;Abrishami;Cochrane Database Syst Rev,2009
4. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation;Paton;Br J Anaesth,2010
5. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment;Chambers;Health Technol Assess,2010
Cited by 124 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of neuromuscular block reversal with neostigmine/glycopyrrolate versus sugammadex on bowel motility recovery after laparoscopic colorectal surgery: A randomized controlled trial;Journal of Clinical Anesthesia;2024-11
2. Evaluation of postoperative residual curarization: a prospective clinical study;Journal of Medical Topics and Updates;2024-08-29
3. Sugammadex vs Neostigmine, a Comparison in Reversing Neuromuscular Blockade: A Narrative Review;Cureus;2024-07-29
4. Impact of neuromuscular block on myocardial injury after non-cardiac surgery (MINS) incidence in the early postoperative stage of older patients undergoing laparoscopic colorectal cancer resection: a randomized controlled study;BMC Geriatrics;2024-06-12
5. Comparison of Different Weight Scalars to Dose Sugammadex for the Reversal of Neuromuscular Blockade in Morbidly Obese Patients: A Systematic Review;Cureus;2024-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3